Literature DB >> 9727036

The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism.

D K Scott1, R M O'Doherty, J M Stafford, C B Newgard, D K Granner.   

Abstract

Phosphoenolpyruvate carboxykinase (PEPCK) is a rate-controlling enzyme in hepatic gluconeogenesis, and it therefore plays a central role in glucose homeostasis. The rate of transcription of the PEPCK gene is increased by glucagon (via cAMP) and glucocorticoids and is inhibited by insulin. Under certain circumstances glucose also decreases PEPCK gene expression, but the mechanism of this effect is poorly understood. The glucose-mediated stimulation of a number of glycolytic and lipogenic genes requires the expression of glucokinase (GK) and increased glucose metabolism. HL1C rat hepatoma cells are a stably transfected line of H4IIE rat hepatoma cells that express a PEPCK promoter-chloramphenicol acetyltransferase fusion gene that is regulated in the same manner as the endogenous PEPCK gene. These cells do not express GK and do not normally exhibit a response of either the endogenous PEPCK gene, or of the trans-gene, to glucose. A recombinant adenovirus that directs the expression of glucokinase (AdCMV-GK) was used to increase glucose metabolism in HL1C cells to test whether increased glucose flux is also required for the repression of PEPCK gene expression. In AdCMV-GK-treated cells glucose strongly inhibits hormone-activated transcription of the endogenous PEPCK gene and of the expressed fusion gene. The glucose effect on PEPCK gene promoter activity is blocked by 5 mM mannoheptulose, a specific inhibitor of GK activity. The glucose analog, 2-deoxyglucose mimics the glucose response, but this effect does not require GK expression. 3-O-methylglucose is ineffective. Glucose exerts its effect on the PEPCK gene within 4 h, at physiologic concentrations, and with an EC50 of 6.5 mM, which approximates the Km of glucokinase. The effects of glucose and insulin on PEPCK gene expression are additive, but only at suboptimal concentrations of both agents. The results of these studies demonstrate that, by inhibiting PEPCK gene transcription, glucose participates in a feedback control loop that governs its production from gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727036     DOI: 10.1074/jbc.273.37.24145

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.

Authors:  Fabienne Foufelle; Pascal Ferré
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

2.  The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1- and ChREBP-controlled pathways.

Authors:  Anaïs Perilhou; Cécile Tourrel-Cuzin; Ilham Kharroubi; Carole Henique; Véronique Fauveau; Tadahiro Kitamura; Christophe Magnan; Catherine Postic; Carina Prip-Buus; Mireille Vasseur-Cognet
Journal:  Mol Cell Biol       Date:  2008-09-02       Impact factor: 4.272

Review 3.  Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues.

Authors:  Rucha Patel; Jasmine Williams-Dautovich; Carolyn L Cummins
Journal:  Mol Endocrinol       Date:  2014-04-25

4.  PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth.

Authors:  Emily D Montal; Ruby Dewi; Kavita Bhalla; Lihui Ou; Bor Jang Hwang; Ashley E Ropell; Chris Gordon; Wan-Ju Liu; Ralph J DeBerardinis; Jessica Sudderth; William Twaddel; Laszlo G Boros; Kenneth R Shroyer; Sekhar Duraisamy; Ronny Drapkin; R Scott Powers; Jason M Rohde; Matthew B Boxer; Kwok-Kin Wong; Geoffrey D Girnun
Journal:  Mol Cell       Date:  2015-10-17       Impact factor: 17.970

5.  Regulation of hepatic energy metabolism and gluconeogenesis by BAD.

Authors:  Alfredo Giménez-Cassina; Luisa Garcia-Haro; Cheol Soo Choi; Mayowa A Osundiji; Elizabeth A Lane; Hu Huang; Muhammed A Yildirim; Benjamin Szlyk; Jill K Fisher; Klaudia Polak; Elaura Patton; Jessica Wiwczar; Marina Godes; Dae Ho Lee; Kirsten Robertson; Sheene Kim; Ameya Kulkarni; Alberto Distefano; Varman Samuel; Gary Cline; Young-Bum Kim; Gerald I Shulman; Nika N Danial
Journal:  Cell Metab       Date:  2014-02-04       Impact factor: 27.287

6.  A role for tubular Na+/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin.

Authors:  Akira Onishi; Yiling Fu; Rohit Patel; Manjula Darshi; Maria Crespo-Masip; Winnie Huang; Panai Song; Brent Freeman; Young Chul Kim; Manoocher Soleimani; Kumar Sharma; Scott Culver Thomson; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-07

7.  Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.

Authors:  Virtu Calabuig-Navarro; Jun Yamauchi; Sojin Lee; Ting Zhang; Yun-Zi Liu; Kelsey Sadlek; Gina M Coudriet; Jon D Piganelli; Chun-Lei Jiang; Rita Miller; Mark Lowe; Hideyoshi Harashima; H Henry Dong
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

8.  Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice.

Authors:  Oludemilade Akinrotimi; Ryan Riessen; Philip VanDuyne; Jung Eun Park; Yoon Kwang Lee; Lee-Jun Wong; Ann M Zavacki; Kristina Schoonjans; Sayeepriyadarshini Anakk
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

9.  Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism.

Authors:  Efren Riu; Tura Ferre; Alex Mas; Antonio Hidalgo; Sylvie Franckhauser; Fatima Bosch
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

10.  A modest glucokinase overexpression in the liver promotes fed expression levels of glycolytic and lipogenic enzyme genes in the fasted state without altering SREBP-1c expression.

Authors:  D K Scott; J J Collier; T T T Doan; A S Bunnell; M C Daniels; D T Eckert; R M O'Doherty
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.